-
Product Insights
Discoidin Domain Containing Receptor 2 – Drugs In Development, 2023
Global Markets Direct’s Discoidin Domain Containing Receptor 2 provides in depth analysis on Discoidin Domain Containing Receptor 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Discoidin...
-
Product Insights
Endothelial PAS Domain Containing Protein 1 – Drugs In Development, 2023
Global Markets Direct’s Endothelial PAS Domain Containing Protein 1 provides in depth analysis on Endothelial PAS Domain Containing Protein 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
T Cell Immunoreceptor With Ig And ITIM Domains – Drugs In Development, 2023
Global Markets Direct’s T Cell Immunoreceptor With Ig And ITIM Domains provides in depth analysis on T Cell Immunoreceptor With Ig And ITIM Domains targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Epithelial Discoidin Domain Containing Receptor 1 – Drugs In Development, 2023
Global Markets Direct’s Epithelial Discoidin Domain Containing Receptor 1 provides in depth analysis on Epithelial Discoidin Domain Containing Receptor 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
NACHT LRR And PYD Domains Containing Protein 3 – Drugs In Development, 2023
Global Markets Direct’s NACHT LRR And PYD Domains Containing Protein 3 provides in depth analysis on NACHT LRR And PYD Domains Containing Protein 3 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Nucleotide Binding Oligomerization Domain Containing Protein 2 – Drugs In Development, 2023
Global Markets Direct’s Nucleotide Binding Oligomerization Domain Containing Protein 2 provides in depth analysis on Nucleotide Binding Oligomerization Domain Containing Protein 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation – Drugs In Development, 2023
Global Markets Direct’s V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation provides in depth analysis on V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Company Insights
Innovation and Patenting activity of Domain Holdings Australia Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Domain Holdings Australia Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SBT-101 in Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SBT-101 in Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SBT-101 in Breast Cancer Drug Details: SBT-101 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KER-012 in Systolic Heart Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KER-012 in Systolic Heart Failure report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KER-012 in Systolic Heart Failure Drug Details: KER-012 is under development...